CD4+ Cancer Research Results

CD4+, CD4+ T Cells: Click to Expand ⟱
Source:
Type:
CD4+ T cells are T lymphocytes that express T cell receptors (TCRs).
Majority of cancer immunotherapies focus on harnessing the anti-tumour CD8+ cytotoxic T cell response, the potential role of CD4+ ‘helper’ T cells has largely remained in the background. multifaceted role of CD4+ T cells in the anti-tumour immune response.
CD4+ T cells play a critical role in developing and sustaining effective anti-tumour immunity, even in cancer immunotherapies specifically designed to activate a CD8+ CTL response.


Nor, Normal Healthy: Click to Expand ⟱
Normal Healthy

Scientific Papers found: Click to Expand⟱
6030- CGA,    Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway
- vitro+vivo, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-453 - in-vitro, Nor, MCF10
NF-kB↓, AntiTum↑, tumCV↓, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, TumCG↓, OS↑, TumMeta↓, CD4+↑, CD8+↑, Imm↑,
6715- dietF,    Are Fermented Foods Effective against Inflammatory Diseases?
- Review, Nor, NA
*Imm↑, *GastroP↑, *Inflam↓, AntiCan↑, *AntiBio↑, *hepatoP↑, *CD4+↑, *IFN-γ↓, *IL17↓, *GutMicro↑, *antiOx↑, *AST↓, *ALAT↓, *HDL↑, *LDL↓, *ROS↓, *lipid-P↓, *Inflam↓, *Aβ↓,
6609- Ech,  Cic,    Echinacea purpurea Extract Enhances Natural Killer Cell Activity In Vivo by Upregulating MHC II and Th1-type CD4+ T Cell Responses
- in-vivo, Nor, NA
*Dose↝, *CD4+↑, *Th1 response↑, *NK cell↑, *Imm↑,
2518- H2,    Hydrogen Therapy Reverses Cancer-Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti-Tumor Immunity
- in-vitro, BC, 4T1 - in-vitro, Nor, 3T3
TumCD↑, CD4+↑, ROS↓,

Showing Research Papers: 1 to 4 of 4

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

ROS↓, 1,  

Cell Death(tgid=5)

Apoptosis↑, 1,   TumCD↑, 1,  

Transcription & Epigenetics(tgid=7)

tumCV↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

EMT↓, 1,   TumCG↓, 1,  

Migration(tgid=13)

TumCI↓, 1,   TumCMig↓, 1,   TumCP↓, 1,   TumMeta↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

CD4+↑, 2,   Imm↑, 1,   NF-kB↓, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 1,   AntiTum↑, 1,   OS↑, 1,  

Infection & Microbiome(tgid=24)

CD8+↑, 1,  
Total Targets: 17

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0)

AntiBio↑, 1,  

Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,   HDL↑, 1,   lipid-P↓, 1,   ROS↓, 1,  

Core Metabolism/Glycolysis(tgid=4)

ALAT↓, 1,   LDL↓, 1,  

Barriers & Transport(tgid=15)

GastroP↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

CD4+↑, 2,   IFN-γ↓, 1,   IL17↓, 1,   Imm↑, 2,   Inflam↓, 2,   NK cell↑, 1,   Th1 response↑, 1,  

Protein Aggregation(tgid=19)

Aβ↓, 1,  

Drug Metabolism & Resistance(tgid=21)

Dose↝, 1,  

Clinical Biomarkers(tgid=22)

ALAT↓, 1,   AST↓, 1,   GutMicro↑, 1,  

Functional Outcomes(tgid=23)

hepatoP↑, 1,  
Total Targets: 21

Scientific Paper Hit Count for: CD4+, CD4+ T Cells
1 Chlorogenic acid
1 diet Fermented Foods
1 Echinacea
1 Cichoric acid / Chicoric acid
1 Hydrogen Gas
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:49  Cells:%  prod#:%  Target#:544  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page